Bone quality assessed using quantitative ultrasound at the distal radius does not differ in antiretroviral therapy-naïve HIV-positive and HIV-negative Rwandan women

E. Mutimura, Q. Shi, D. R. Hoover, Kathryn Anastos, E. Rudakemwa, J. C. Dusingize, J. D. Sinabye, M. T. Yin

Research output: Contribution to journalArticle

1 Scopus citations


Objectives: The incidence of fractures appears to be increased in HIV-infected individuals. Methods: We assessed bone quality using quantitative ultrasound (QUS) in HIV-infected and uninfected Rwandan women. A Sunlight Omnisense 7000 QUS was used to measure the speed of ultrasound (SOS) at the distal radius in 646 antiretroviral therapy (ART)-naïve HIV-infected women and 211 HIV-uninfected women. The Z-scores for SOS were based on data for women of the same age from the manufacturer's reference material. Results: The mean CD4 cell count was 285 (± 166) cells/μL in the HIV-positive women. SOS Z-scores adjusted and unadjusted for body mass index did not differ between the groups. SOS did not differ by CD4 count (< 200 vs. ≥ 200 cells/μL: 4016 (± 117) vs. 4028 (± 107) m/s, respectively; p=0.19. Conclusions: In HIV-positive ART-naïve Rwandan women with advanced HIV disease, bone quality at the distal radius was similar to that in HIV-negative controls.

Original languageEnglish (US)
Pages (from-to)724-727
Number of pages4
JournalHIV Medicine
Issue number10
StatePublished - Nov 1 2016



  • antiretroviral therapy
  • antiretroviral therapy-naïve
  • bone mineral density
  • HIV
  • women

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)
  • Infectious Diseases

Cite this